Study of AZD3152 Intramuscular Injection or Intravenous Infusion in Healthy Japanese Adult Participants

Clinical trial NCT05932641 · COMPLETED

Trial details

NCT number: NCT05932641
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

COVID-19, SARS-CoV-2

Start date: 2023-07-31
Primary completion: 2024-12-05
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.